Medicine
Meprobamate 400 mg tablet
Meprobamate 400 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, excursions permitted to 15°C-30°C…
Key facts
- Active ingredient (INN)
- Meprobamate
- Brand
- Sold under the generic name
- Strength
- 400 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 1000 tablets and 4 more
- Manufacturers
- Alembic PharmaceuticalsIndiaCiplaIndia
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, excursions permitted to 15°C-30°C (59°F-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIV
- ATC code
- N05BC01 Meprobamate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 July 2013
- Identifiers
- RxCUI 197928, 197929DailyMed set ID 3b255bcd-0218-44f8-830b-971f5ec45276, a0891a32-105b-48bc-a246-5e179d2e7fa1, 17d814e2-b277-4dce-8615-e7fd7cab773fNDC 62332-020, 46708-020, 69097-975Application ANDA090122, ANDA040797
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 46708-020-30 | Alembic PharmaceuticalsIndia | 23 July 2013 |
| 100 tablet in 1 bottle | 46708-020-71 | Alembic PharmaceuticalsIndia | 23 July 2013 |
| 1000 tablet in 1 bottle | 46708-020-91 | Alembic PharmaceuticalsIndia | 23 July 2013 |
| 30 tablet in 1 bottle | 62332-020-30 | Alembic PharmaceuticalsIndia | 31 March 2016 |
| 100 tablet in 1 bottle | 62332-020-31 | Alembic PharmaceuticalsIndia | 31 March 2016 |
| 1000 tablet in 1 bottle | 62332-020-91 | Alembic PharmaceuticalsIndia | 31 March 2016 |
| 100 tablet in 1 bottle | 69097-975-07 | CiplaIndia | 7 June 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 April 1955 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Meprobamate
Clinical summary
Meprobamate is a prescription medicine. It is available as tablets for oral use. MedsAcross supplies Meprobamate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MeprobamateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Meprobamate prescribing information (Cipla) · U.S. National Library of Medicine, DailyMed
Need Meprobamate 400 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.